- Home
- ONCY vs KOSS Comparison
ONCY vs KOSS Comparison
Compare ONCY & KOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- KOSS
- Stock Information
- Founded
- ONCY 1998
- KOSS 1953
- Country
- ONCY Canada
- KOSS United States
- Employees
- ONCY N/A
- KOSS N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- KOSS Consumer Electronics/Appliances
- Sector
- ONCY Health Care
- KOSS Consumer Staples
- Exchange
- ONCY Nasdaq
- KOSS Nasdaq
- Market Cap
- ONCY 49.1M
- KOSS 39.9M
- IPO Year
- ONCY 1999
- KOSS N/A
- Fundamental
- Price
- ONCY $0.52
- KOSS $4.92
- Analyst Decision
- ONCY Strong Buy
- KOSS
- Analyst Count
- ONCY 3
- KOSS 0
- Target Price
- ONCY $4.33
- KOSS N/A
- AVG Volume (30 Days)
- ONCY 333.0K
- KOSS 23.9K
- Earning Date
- ONCY 05-14-2025
- KOSS 05-08-2025
- Dividend Yield
- ONCY N/A
- KOSS N/A
- EPS Growth
- ONCY N/A
- KOSS N/A
- EPS
- ONCY N/A
- KOSS N/A
- Revenue
- ONCY N/A
- KOSS $12,433,361.00
- Revenue This Year
- ONCY N/A
- KOSS N/A
- Revenue Next Year
- ONCY N/A
- KOSS N/A
- P/E Ratio
- ONCY N/A
- KOSS N/A
- Revenue Growth
- ONCY N/A
- KOSS N/A
- 52 Week Low
- ONCY $0.47
- KOSS $3.12
- 52 Week High
- ONCY $1.53
- KOSS $18.73
- Technical
- Relative Strength Index (RSI)
- ONCY 41.53
- KOSS 54.53
- Support Level
- ONCY $0.54
- KOSS $4.51
- Resistance Level
- ONCY $0.65
- KOSS $5.07
- Average True Range (ATR)
- ONCY 0.04
- KOSS 0.24
- MACD
- ONCY -0.00
- KOSS 0.05
- Stochastic Oscillator
- ONCY 13.36
- KOSS 78.57
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About KOSS Koss Corporation
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones.